Private company
Sofinnova Venture Partners X, L.P.
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Sofinnova Venture Partners X, L.P. sits at the top of its group. 7 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Sofinnova Venture Partners X, L.P. DE
- CinCor Pharma, Inc. Stake · Waltham, Massachusetts
- Inozyme Pharma, Inc. Stake · Boston, Massachusetts
- Jade Biosciences, Inc. Stake · Waltham, Massachusetts
- Karuna Therapeutics Stake · Boston
- Vera Therapeutics, Inc. Stake · Brisbane, California
- Y-mAbs Therapeutics, Inc. Stake · Princeton, New Jersey
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.
Stakes it holds
Sofinnova Venture Partners X, L.P. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).
- Jade Biosciences, Inc.SCHEDULE 13D/A Feb 6, 2023 to Mar 5, 20262
- Vera Therapeutics, Inc.SCHEDULE 13D/A Feb 6, 2023 to Mar 5, 20263
- Inozyme Pharma, Inc.SC 13D/A Feb 20, 20244
- Karuna TherapeuticsSC 13D/A Feb 6, 2023 to Jun 21, 20235
- CinCor Pharma, Inc.SC 13D/A Jan 21, 2022 to Mar 1, 20236
- Y-mAbs Therapeutics, Inc.SC 13D/A Feb 15, 20227
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7